Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

Wellington Sun; Dennis Cunningham; Steven S. Wasserman; Judith Perry; J. Robert Putnak; Kenneth H. Eckels; David W. Vaughn; Stephen J. Thomas; Niranjan Kanesa-Thasan; Bruce L. Innis; Robert Edelman

doi:10.4161/hv.5.1.6348

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

Human Vaccines ◽

10.4161/hv.5.1.6348 ◽

2009 ◽

Vol 5 (1) ◽

pp. 33-40 ◽

Cited By ~ 79

Author(s):

Wellington Sun ◽

Dennis Cunningham ◽

Steven S. Wasserman ◽

Judith Perry ◽

J. Robert Putnak ◽

...

Keyword(s):

Clinical Trial ◽

Phase 2 ◽

Dengue Vaccine ◽

Phase 2 Clinical Trial

Download Full-text

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.9 ◽

2019 ◽

Vol 3 ◽

pp. S9

Author(s):

Zoe Draelos ◽

Fran Cook-Bolden ◽

Lawrence Green ◽

Eric Guenin ◽

Gina Martin ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase 2 ◽

Patient Reported ◽

Phase 2 Clinical Trial

Abstract not available.

Download Full-text

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Case Medical Research ◽

10.31525/ct1-nct04283669 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Neurofibromatosis Type ◽

Neurofibromatosis Type 2 ◽

Vestibular Schwannomas ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047842.497861 ◽

2006 ◽

Author(s):

David Sullivan

Keyword(s):

Clinical Trial ◽

Plasmodium Falciparum ◽

Combination Therapy ◽

Falciparum Malaria ◽

Plasmodium Falciparum Malaria ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Uncomplicated Plasmodium Falciparum Malaria ◽

Randomized Phase 2

Download Full-text

Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727784209.793552909 ◽

2018 ◽

Author(s):

Warren A Chow

Keyword(s):

Clinical Trial ◽

Macrophage Infiltration ◽

Phase 2 ◽

Pathway Activation ◽

Phase 2 Clinical Trial

Download Full-text

Phase 2 Clinical Trial of Intraoral Grafting of Human Tissue-Engineered Oral Mucosa

10.21236/ada591622 ◽

2013 ◽

Author(s):

Stephen E. Feinberg

Keyword(s):

Clinical Trial ◽

Oral Mucosa ◽

Human Tissue ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

A Descriptive Cost‐Analysis of MYX.1/MCRN003, a Phase 2 Clinical Trial Evaluating High‐dose Weekly Carfilzomib, Cyclophosphamide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma

European Journal Of Haematology ◽

10.1111/ejh.13671 ◽

2021 ◽

Author(s):

Bethany E. Monteith ◽

Christopher P. Venner ◽

Matthew C. Cheung ◽

Joe Pater ◽

Lois Shepherd ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Cost Analysis ◽

High Dose ◽

Phase 2 ◽

Refractory Multiple Myeloma ◽

Phase 2 Clinical Trial

Download Full-text

Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder

Journal of Affective Disorders ◽

10.1016/j.jad.2021.02.027 ◽

2021 ◽

Vol 285 ◽

pp. 112-119

Author(s):

Alix Arnaud ◽

Ellison Suthoff ◽

Katie Stenson ◽

Brian Werneburg ◽

Paul Hodgkins ◽

...

Keyword(s):

Clinical Trial ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Number Needed To Treat ◽

Phase 2 ◽

Major Depressive ◽

Phase 2 Clinical Trial ◽

Clinical Trial Results ◽

Number Needed To Harm

Download Full-text

41. Repeated Autologous Infusions of Cells Modified with VSV-G-Pseudotyped Lentiviral Vector VRX496 Can Induce Anti-VSV-G Humoral Response in Humans without Clinical Consequence or Effect on Modified Cells Persistence: Findings from Lexgenleucel-T Phase 2 Clinical Trial

Molecular Therapy ◽

10.1016/s1525-0016(16)37482-2 ◽

2010 ◽

Vol 18 ◽

pp. S17-S18

Keyword(s):

Clinical Trial ◽

Lentiviral Vector ◽

Humoral Response ◽

Clinical Consequence ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

T Phase

Download Full-text

Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.02.019 ◽

2021 ◽

Author(s):

Mateusz J. Spałek ◽

Hanna Koseła-Paterczyk ◽

Aneta Borkowska ◽

Michał Wągrodzki ◽

Anna Szumera-Ciećkiewicz ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcomas ◽

Hypofractionated Radiotherapy ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Efficacy of SPI-1005 for Prevention of Noise-Induced Hearing Loss: Phase 2 Clinical Trial Results

Otolaryngology ◽

10.1177/0194599814541627a172 ◽

2014 ◽

Vol 151 (1_suppl) ◽

pp. P83-P84 ◽

Cited By ~ 3

Author(s):

Jonathan Kil ◽

Eric D. Lynch ◽

Scott Griffiths ◽

Edward Lobarinas ◽

Christopher Spankovich ◽

...

Keyword(s):

Clinical Trial ◽

Hearing Loss ◽

Noise Induced Hearing Loss ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Clinical Trial Results

Download Full-text